Nature aging · 2025
Cerebrospinal fluid proteomic signatures in cognitively normal individuals identify distinct clusters linked to neurodegeneration.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Seo Dahun, Do Anh N, Heo Gyujin, Kwon Jiseon, Song Soomin, Apio Catherine, Lee Cheolmin Matthew, Timsina Jigyasha, Gong Katherine, Chen Yike, Liu Menghan, Kohlfeld Pat, Budde John, Boada Merce, Orellana Adelina, Fernandez Maria Victoria, Ruiz Agustin, Morris John C, Schindler Suzanne E, Ibanez Laura, Park Taesung, Cruchaga Carlos, Sung Yun Ju
Аннотация
Age and APOE ε4 are major risk factors for Alzheimer's disease (AD), while sex differences exist in disease prevalence and progression. Cerebrospinal fluid (CSF) proteomics can provide additional insights into brain aging and AD. To examine proteomic changes due to age, sex and apolipoprotein E (APOE) ε4 along with amyloid status before clinical AD occurs, we profiled 6,175 proteins in the CSF from 994 cognitively normal individuals aged 43-91 years. We identified and replicated 2,172 age-associated, 711 sex-associated, 193 APOE ε4-associated and 1,807 amyloid-associated proteins, with extensive overlap suggesting their interplay. These CSF-specific signatures were distinct from those in plasma. Network analysis revealed two proteomic modules-M2 (age-associated, sex-associated and amyloid-associated) and M6 (age-associated and sex-associated)-which were linked to neuropsychiatric and aging-related diseases. Together, our study provides proteomic changes during the early phase of AD, which may help identify new therapeutic targets of AD.